B22956/1, a new intravascular contrast agent for MRI: first administration to 
humans-preliminary results

La Noce, A; Stoelben S, Scheffler, K; Hennig J, Lenz HM, La Ferla R, Lorusso V, Maggioni, F; Cavagna, F

doi:10.1016/S1076-6332(03)80245-3

Item

ITEM ACTIONSEXPORT

Add to Basket

Please note that a newer version of this item is available:
https://pure.mpg.de/pubman/item/item_1792784_2

DetailsSummary

Released

Journal Article

B22956/1, a new intravascular contrast agent for MRI: first administration to humans-preliminary results

MPS-Authors

/persons/resource/persons84187

Stoelben S, Scheffler, K
Department High-Field Magnetic Resonance, Max Planck Institute for Biological Cybernetics, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

La Noce, A., Stoelben S, Scheffler, K., Hennig J, Lenz HM, La Ferla R, Lorusso V, Maggioni, F., & Cavagna, F. (2002). B22956/1, a new intravascular contrast agent for MRI: first administration to humans-preliminary results. Academic Radiology, 9(2 Supplement), S404-S406. doi:10.1016/S1076-6332(03)80245-3.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0013-DF2C-E

Abstract

There is no abstract available